Spike Proteins: A Pathology All-Round By Brian Simpson
At a time when the US is moving under the Biden regime to Covid mandates once more, as we have covered in detail in recent days at the blog, evidence is slowly being published in mainstream medical journals about the dangers of the Covid spike protein, both from the infection, and from the vaccination.
A new paper in the journal, Biomedicines, “Spikeopathy’: COVID-19 Spike Protein Is Pathogenic, from Both Virus and Vaccine mRNA," covers all of the evidence of the harms arising from the spike proteins, which are in short, extremely toxic, and the last thing one wants the body to be producing in the trillions. This is worth a read for those who are concerned, if they have been vaxxed, or like most of the rest of us, are concerned that the World Health Organization pandemic treaty could lead to compulsory vaccinations with any number of experimental vaccines.
https://www.mdpi.com/2227-9059/11/8/2287
‘Spikeopathy’: COVID-19 Spike Protein Is Pathogenic, from Both Virus and Vaccine mRNA
by
Biomedicines 2023, 11(8), 2287; https://doi.org/10.3390/biomedicines11082287
Abstract
The COVID-19 pandemic caused much illness, many deaths, and profound disruption to society. The production of ‘safe and effective’ vaccines was a key public health target. Sadly, unprecedented high rates of adverse events have overshadowed the benefits. This two-part narrative review presents evidence for the widespread harms of novel product COVID-19 mRNA and adenovectorDNA vaccines and is novel in attempting to provide a thorough overview of harms arising from the new technology in vaccines that relied on human cells producing a foreign antigen that has evidence of pathogenicity. This first paper explores peer-reviewed data counter to the ‘safe and effective’ narrative attached to these new technologies. Spike protein pathogenicity, termed ‘spikeopathy’, whether from the SARS-CoV-2 virus or produced by vaccine gene codes, akin to a ‘synthetic virus’, is increasingly understood in terms of molecular biology and pathophysiology. Pharmacokinetic transfection through body tissues distant from the injection site by lipid-nanoparticles or viral-vector carriers means that ‘spikeopathy’ can affect many organs. The inflammatory properties of the nanoparticles used to ferry mRNA; N1-methylpseudouridine employed to prolong synthetic mRNA function; the widespread biodistribution of the mRNA and DNA codes and translated spike proteins, and autoimmunity via human production of foreign proteins, contribute to harmful effects. This paper reviews autoimmune, cardiovascular, neurological, potential oncological effects, and autopsy evidence for spikeopathy. With many gene-based therapeutic technologies planned, a re-evaluation is necessary and timely.”
Comments